133 related articles for article (PubMed ID: 14871986)
21. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
[TBL] [Abstract][Full Text] [Related]
22. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
23. High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis.
von Knobloch R; Hegele A; Brandt H; Varga Z; Wille S; Kälble T; Heidenreich A; Hofmann R
Int J Cancer; 2002 Apr; 98(6):889-94. PubMed ID: 11948468
[TBL] [Abstract][Full Text] [Related]
24. Use of archival fine-needle aspirates for the allelotyping of tumors.
Euhus DM; Maitra A; Wistuba II; Ashfaq R; Alberts A; Gibbons D; Gazdar AF
Cancer; 1999 Dec; 87(6):372-9. PubMed ID: 10603191
[TBL] [Abstract][Full Text] [Related]
25. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
Halling KC; French AJ; McDonnell SK; Burgart LJ; Schaid DJ; Peterson BJ; Moon-Tasson L; Mahoney MR; Sargent DJ; O'Connell MJ; Witzig TE; Farr GH; Goldberg RM; Thibodeau SN
J Natl Cancer Inst; 1999 Aug; 91(15):1295-303. PubMed ID: 10433618
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
28. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
[TBL] [Abstract][Full Text] [Related]
29. Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.
Chan MW; Hui AB; Yip SK; Ng CF; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Int J Oncol; 2009 Apr; 34(4):963-70. PubMed ID: 19287953
[TBL] [Abstract][Full Text] [Related]
30. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
31. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
von Knobloch R; Hegele A; Brandt H; Olbert P; Heidenreich A; Hofmann R
Int J Cancer; 2001 Oct; 94(1):67-72. PubMed ID: 11668480
[TBL] [Abstract][Full Text] [Related]
32. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).
Doll JA; Zhu X; Furman J; Kaleem Z; Torres C; Humphrey PA; Donis-Keller H
Am J Pathol; 1999 Sep; 155(3):967-71. PubMed ID: 10487854
[TBL] [Abstract][Full Text] [Related]
35. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal basis of adenocarcinoma of the prostate.
Verma RS; Manikal M; Conte RA; Godec CJ
Cancer Invest; 1999; 17(6):441-7. PubMed ID: 10434955
[TBL] [Abstract][Full Text] [Related]
37. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
[TBL] [Abstract][Full Text] [Related]
38. Allelic imbalance and microsatellite instability in chromosomes 2p, 3p, 5q, and 18q in esophageal squamous carcinoma in patients from South Africa.
Naidoo R; Tarin M; Reddi A; Chetty R
Diagn Mol Pathol; 1999 Sep; 8(3):131-7. PubMed ID: 10565684
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal aberrations in prostate cancer.
Saramaki O; Visakorpi T
Front Biosci; 2007 May; 12():3287-301. PubMed ID: 17485299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]